Literature DB >> 22125955

Pharmacological studies on seeds of Alangium salvifolium Linn.

Ashish Kumar Sharma1, Vipin Agarwal, Rajesh Kumar, Arumugam Balasubramaniam, Anurag Mishra, Rajiv Gupta.   

Abstract

The seeds of Alangium salvifolium Linn. have been traditionally reported to exhibit a variety of biological activities, including antidiabetic, anticancer, diuretic, anti-inflammatory, antimicrobial, laxative, and antiepileptic activities. The objective of this study was to verify the traditional claims and to evaluate the seeds of Alangium salvifolium in various organic extracts to screen the antidiabetic, antiepileptic, analgesic and antiinflammatory activities. The chloroform, ethanol, and water extracts of Alangium salvifolium seeds were obtained and subjected for phytochemical screening and evaluated for their pharmacological activities. From the acute toxicity study it was observed that chloroform, ethanol, and aqueous extracts of Alangium salvifolium seeds are non-toxic at a fixed dose of 2000 mg/kg. Among all three extracts ethanol extracts exhibited significant (p < 0.01) antidiabetic, antiepileptic, analgesic and anti-inflammatory activities. The phytochemical analysis revealed the presence of alkaloids, glycosides, terpenoids, steroids and tannins. The results of present study verified the traditional claims made by ayurvedic practitioner. However, the chemical constituents responsible for the pharmacological activities remain to be investigated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22125955

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  2 in total

1.  Sub-chronic safety evaluation of aqueous extract of Alangium salvifolium (L.f.) Wangerin leaves in rats.

Authors:  Bhupinder Kapoor; Gagandeep Kaur; Mukta Gupta; Reena Gupta
Journal:  J Adv Pharm Technol Res       Date:  2017 Jul-Sep

2.  Evaluation of analgesic activity and toxicity of alkaloids in Myristica fragrans seeds in mice.

Authors:  A Al-Shammary Hayfaa; Aa Malik Al-Saadi Sahar; M Al-Saeidy Awatif
Journal:  J Pain Res       Date:  2013-07-31       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.